A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin

BACKGROUND: Chemodynamic therapy (CDT) relying on intracellular iron ions and H(2)O(2) is a promising therapeutic strategy due to its tumor selectivity, which is limited by the not enough metal ions or H(2)O(2) supply of tumor microenvironment. Herein, we presented an efficient CDT strategy based on...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiao-Xin, Xu, Xiang, Wang, Mei-Fang, Xu, Hua-Zhen, Peng, Xing-Chun, Han, Ning, Yu, Ting-Ting, Li, Liu-Gen, Li, Qi-Rui, Chen, Xiao, Wen, Yu, Li, Tong-Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107746/
https://www.ncbi.nlm.nih.gov/pubmed/35568865
http://dx.doi.org/10.1186/s12951-022-01455-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107746/
https://www.ncbi.nlm.nih.gov/pubmed/35568865
http://dx.doi.org/10.1186/s12951-022-01455-0

Ejemplares similares